Neoleukin Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
1.30
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
5
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.30
|
-0.24
|
0.06
|
20.00%
|
|
2022-06-30
|
-0.30
|
-0.28
|
0.02
|
6.67%
|
|
2022-03-31
|
-0.30
|
-0.28
|
0.02
|
6.67%
|
|
2021-12-31
|
-0.30
|
-0.28
|
0.02
|
6.67%
|
|
2021-09-30
|
-0.28
|
-0.28
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.26
|
-0.27
|
-0.01
|
-3.85%
|
|
2021-03-31
|
-0.23
|
-0.27
|
-0.04
|
-17.39%
|
|
2020-12-31
|
-0.25
|
-0.24
|
0.01
|
4.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.80
|
|
2021-12-31
|
-1.10
|
|
2020-12-31
|
-0.66
|
|
2019-12-31
|
-2.66
|
|
2018-12-31
|
-1.35
|
|
2017-12-31
|
-2.14
|
|
2016-12-31
|
-1.96
|
|
2015-12-31
|
-1.73
|
|
2014-12-31
|
-3.16
|